Dermira Inc (DERM)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

275 MIDDLEFIELD ROAD MENLO PARK, CA 94025

Dermira, Inc. develops and commercializes dermatology therapies. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases.

Data based on most recent fiscal year report
Market Cap1.044 Billion Shares Outstanding54.52 Million Avg Volume1.878 Million
1-Yr BETA vs S&P TR Current Ratio8.7 Quick Ratio8.48
View SEC Filings from DERM instead.

View recent insider trading info

Funds Holding DERM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DERM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

40.9 Million total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RINGO WILLIAM R CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-03-19 3

BAY CITY CAPITAL LLC

BAY CITY CAPITAL MANAGEMENT V LLC

BAY CITY CAPITAL FUND V, L.P.

BAY CITY CAPITAL FUND V CO-INVESTMENT FUND, L.P.

  • 10% Owner
1,393,612 2020-03-16 0

MOTT DAVID M

  • Director
0 2020-03-16 0

GILBERT HALLEY E CHIEF ADMIN OFFICER & SVP

  • Officer
265,991 2020-02-21 3

BAUER EUGENE A CHIEF MEDICAL OFFICER

0 2020-02-20 3

FUST MATTHEW K

0 2020-02-20 6

CRAVES FRED B

0 2020-02-20 3

COHEN DAVID E

0 2020-02-20 3

MCDADE MARK

0 2020-02-20 3

GUGGENHIME ANDREW CFO

0 2020-02-20 3

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

0 2020-02-20 3

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

0 2020-02-20 2

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

0 2020-02-20 3

NUNN JASON RALEIGH

0 2020-02-20 3

SEBELIUS KATHLEEN

0 2020-02-20 3

LYONS-WILLIAMS LORI CHIEF COMMERCIAL OFFICER

0 2020-02-20 3

HORAN CHRISTOPHER CHIEF TECHNICAL OPS OFFICER

0 2020-02-20 2

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

0 2020-02-20 3

BALD EAGLE ACQUISITION CORP

ELI LILLY & CO

  • 10% Owner
100 2020-02-20 2

BARRIS PETER J

  • Director
0 2020-02-06 0

BASKETT FOREST

  • 10% Owner
0 2020-01-29 0

SANDELL SCOTT D

  • 10% Owner
0 2020-01-29 0

CANAAN VIII LP

CANAAN PARTNERS VIII LLC

  • 10% Owner
2,917,169 2019-12-27 0

KERINS PATRICK J

  • 10% Owner
9,569,451 2019-12-09 0

BARRETT M JAMES

  • Director
0 2019-05-30 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

  • 10% Owner
0 2019-01-22 0

VISWANATHAN RAVI

  • 10% Owner
5,000,000 2018-10-17 0

CAEYMAEX EMMANUEL

  • Director
0 2016-12-21 0

KOLLURI KRISHNA KITTU

  • 10% Owner
5,215,128 2016-12-19 0

WELLER HARRY R

  • 10% Owner
3,490,073 2016-10-31 0

HUTTON WENDE S

  • Director
0 2015-06-11 0

DRANT RYAN D

  • 10% Owner
7,489,485 2015-06-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 15,000 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 52,500 d 0 0.00 direct

LYONS-WILLIAMS LORI CHIEF COMMERCIAL OFFICER

2020-02-20 D 65,000 d 0 0.00 direct

BALD EAGLE ACQUISITION CORP - > 10% Owner

ELI LILLY & CO - > 10% Owner

2020-02-20 P 40,926,025 $18.75 a 100 100.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 60,000 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 98,430 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 103,258 d 0 0.00 direct

LYONS-WILLIAMS LORI CHIEF COMMERCIAL OFFICER

2020-02-20 D 25,401 $18.75 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 71,397 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 164,642 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER by the bauer family 1995 trust

2020-02-20 D 16,206 $18.75 d 0 0.00 indirect

FUST MATTHEW K

2020-02-20 D 6,000 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 18,233 $18.75 d 0 0.00 direct

FUST MATTHEW K

2020-02-20 D 10,344 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 25,000 d 0 0.00 direct

COHEN DAVID E

2020-02-20 D 6,000 d 0 0.00 direct

RINGO WILLIAM R

2020-02-20 D 6,000 d 0 0.00 direct

MCDADE MARK

2020-02-20 D 3,000 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 937 d 0 0.00 direct

COHEN DAVID E

2020-02-20 D 10,344 d 0 0.00 direct

RINGO WILLIAM R

2020-02-20 D 8,620 d 0 0.00 direct

HORAN CHRISTOPHER CHIEF TECHNICAL OPS OFFICER

2020-02-20 D 65,000 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 8,000 d 0 0.00 direct

COHEN DAVID E

2020-02-20 D 17,241 d 0 0.00 direct

GILBERT HALLEY E

2020-02-20 D 20,000 d 0 0.00 direct

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 6,000 d 0 0.00 direct

MCDADE MARK

2020-02-20 D 6,000 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 46,371 d 0 0.00 direct

SEBELIUS KATHLEEN

2020-02-20 D 6,000 d 0 0.00 direct

CRAVES FRED B

2020-02-20 D 6,000 d 0 0.00 direct

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 708 d 0 0.00 direct

MCDADE MARK

2020-02-20 D 23,275 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 33,224 d 0 0.00 direct

SEBELIUS KATHLEEN

2020-02-20 D 6,896 d 0 0.00 direct

CRAVES FRED B

2020-02-20 D 10,334 d 0 0.00 direct

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 6,250 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 25,000 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 15,000 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 50,000 d 0 0.00 direct

CRAVES FRED B see footnote 3

2020-02-20 D 3,441,075 $18.75 d 0 0.00 indirect

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 7,040 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 65,000 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 300,000 d 0 0.00 direct

NUNN JASON RALEIGH

2020-02-20 D 6,000 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 5,700 d 0 0.00 direct

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 67,500 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 71,250 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 2,437 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 180,000 d 0 0.00 direct

NUNN JASON RALEIGH

2020-02-20 D 10,334 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 57,000 d 0 0.00 direct

LYONS-WILLIAMS LORI CHIEF COMMERCIAL OFFICER

2020-02-20 D 30,000 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 121 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 48,750 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 9,528 d 0 0.00 direct

LYONS-WILLIAMS LORI CHIEF COMMERCIAL OFFICER

2020-02-20 D 63,750 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 50,178 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 64,327 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 32,758 d 0 0.00 direct

FUST MATTHEW K

2020-02-20 D 3,000 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 32,506 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD by the wiggans living trust dated 5/14/02

2020-02-20 D 180,985 $18.75 d 0 0.00 indirect

FUST MATTHEW K

2020-02-20 D 6,000 d 0 0.00 direct

COHEN DAVID E

2020-02-20 D 3,000 d 0 0.00 direct

RINGO WILLIAM R

2020-02-20 D 3,000 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 3,726 $18.75 d 0 0.00 direct

FUST MATTHEW K

2020-02-20 D 14,224 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 2,100 d 0 0.00 direct

COHEN DAVID E

2020-02-20 D 6,000 d 0 0.00 direct

RINGO WILLIAM R

2020-02-20 D 6,000 d 0 0.00 direct

HORAN CHRISTOPHER CHIEF TECHNICAL OPS OFFICER

2020-02-20 D 15,000 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 65,000 d 0 0.00 direct

COHEN DAVID E

2020-02-20 D 14,224 d 0 0.00 direct

RINGO WILLIAM R

2020-02-20 D 18,275 d 0 0.00 direct

HORAN CHRISTOPHER CHIEF TECHNICAL OPS OFFICER

2020-02-20 D 140,000 d 0 0.00 direct

MCDADE MARK

2020-02-20 D 6,000 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 18,750 d 0 0.00 direct

COHEN DAVID E

2020-02-20 D 35,682 $18.75 d 0 0.00 direct

CRAVES FRED B

2020-02-20 D 3,000 d 0 0.00 direct

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 10,000 d 0 0.00 direct

MCDADE MARK

2020-02-20 D 10,344 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 20,869 d 0 0.00 direct

SEBELIUS KATHLEEN

2020-02-20 D 6,000 d 0 0.00 direct

CRAVES FRED B

2020-02-20 D 6,000 d 0 0.00 direct

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 2,814 d 0 0.00 direct

MCDADE MARK

2020-02-20 D 6,000 $18.75 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 87,990 d 0 0.00 direct

SEBELIUS KATHLEEN

2020-02-20 D 20,689 d 0 0.00 direct

CRAVES FRED B see footnote 5

2020-02-20 D 30,000 $18.75 d 0 0.00 indirect

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 28,000 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 5,700 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 25,000 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 15,000 d 0 0.00 direct

NUNN JASON RALEIGH

2020-02-20 D 3,000 d 0 0.00 direct

CRAVES FRED B see footnote 2

2020-02-20 D 6,000 $18.75 d 0 0.00 indirect

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 28,130 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 57,000 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 150,000 d 0 0.00 direct

NUNN JASON RALEIGH

2020-02-20 D 6,000 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 2,437 d 0 0.00 direct

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 30,089 $18.75 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 67,240 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 65,000 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 355,170 d 0 0.00 direct

NUNN JASON RALEIGH

2020-02-20 D 6,000 $18.75 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 48,750 d 0 0.00 direct

LYONS-WILLIAMS LORI CHIEF COMMERCIAL OFFICER

2020-02-20 D 6,378 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 41,951 $18.75 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 10,000 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 16,332 d 0 0.00 direct

LYONS-WILLIAMS LORI CHIEF COMMERCIAL OFFICER

2020-02-20 D 100,000 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 17,062 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 115,022 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 110,434 d 0 0.00 direct

FUST MATTHEW K

2020-02-20 D 6,000 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 88,251 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 49,963 $18.75 d 0 0.00 direct

FUST MATTHEW K

2020-02-20 D 10,344 d 0 0.00 direct

COHEN DAVID E

2020-02-20 D 6,000 d 0 0.00 direct

RINGO WILLIAM R

2020-02-20 D 6,000 d 0 0.00 direct

FUST MATTHEW K

2020-02-20 D 5,051 $18.75 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 2,814 d 0 0.00 direct

COHEN DAVID E

2020-02-20 D 10,344 d 0 0.00 direct

RINGO WILLIAM R

2020-02-20 D 10,344 d 0 0.00 direct

HORAN CHRISTOPHER CHIEF TECHNICAL OPS OFFICER

2020-02-20 D 53,333 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 48,130 d 0 0.00 direct

COHEN DAVID E

2020-02-20 D 8,620 d 0 0.00 direct

RINGO WILLIAM R

2020-02-20 D 6,000 $18.75 d 0 0.00 direct

HORAN CHRISTOPHER CHIEF TECHNICAL OPS OFFICER

2020-02-20 D 21,400 $18.75 d 0 0.00 direct

MCDADE MARK

2020-02-20 D 6,000 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 21,560 d 0 0.00 direct

SEBELIUS KATHLEEN

2020-02-20 D 3,000 d 0 0.00 direct

CRAVES FRED B

2020-02-20 D 6,000 d 0 0.00 direct

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 22,500 d 0 0.00 direct

MCDADE MARK

2020-02-20 D 7,758 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 719 d 0 0.00 direct

SEBELIUS KATHLEEN

2020-02-20 D 6,000 d 0 0.00 direct

CRAVES FRED B

2020-02-20 D 10,344 d 0 0.00 direct

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 574 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 15,000 d 0 0.00 direct

GRIFFITH CHRISTOPHER M. CHIEF BUSINESS & STRATEGY OFF

2020-02-20 D 67,242 $18.75 d 0 0.00 direct

SEBELIUS KATHLEEN

2020-02-20 D 6,000 $18.75 d 0 0.00 direct

CRAVES FRED B see footnote 4

2020-02-20 D 65,572 $18.75 d 0 0.00 indirect

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 50,000 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 3,562 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 9,000 d 0 0.00 direct

NUNN JASON RALEIGH

2020-02-20 D 6,000 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 15,000 d 0 0.00 direct

AURORA DALJIT SINGH CHIEF SCIENTIFIC AFFAIRS OFF

2020-02-20 D 11,500 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 71,250 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 6,378 d 0 0.00 direct

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-20 D 180,000 d 0 0.00 direct

NUNN JASON RALEIGH

2020-02-20 D 10,344 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-20 D 65,000 d 0 0.00 direct

LYONS-WILLIAMS LORI CHIEF COMMERCIAL OFFICER

2020-02-20 D 15,000 d 0 0.00 direct

GUGGENHIME ANDREW CFO

2020-02-20 D 73,287 d 0 0.00 direct

PENA LUIS C. CHIEF DEVELOPMENT OFFICER

2020-02-20 D 63,750 d 0 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER

2020-02-11 G 12,924 d 3,726 0.00 direct

BAUER EUGENE A CHIEF MEDICAL OFFICER by the bauer family 1995 trust

2020-02-11 G 10,772 d 16,206 0.00 indirect

WIGGANS THOMAS G CEO & CHAIRMAN OF THE BOARD

2020-02-05 G 27,000 d 49,963 0.00 direct

Elevate your investments